SubsidieMeestersEasy to use, contactless Dual-Mode Ultrasound Technology for high accuracy treatment of Atrial Fibrillation, improving outcomes
Healium aims to revolutionize cardiac ablation with proprietary ultrasound technology for contactless tissue ablation and real-time monitoring, transitioning to clinical studies with €12.75M funding.
Projectdetails
Introduction
Our mission is to radically change the landscape of cardiac ablation. Our products, based on proprietary ultrasound technology, allow contactless tissue ablation with real-time lesion monitoring, bringing Healium to the forefront of the cardiac ablation market.
Team Overview
Our team, backed by scientific and business advisors, includes:
- Dr. Eckhouse, Chairman: A leading medical entrepreneur who has founded over 20 companies and accumulated over €1B in exits (Ventor for $325M, Synron and Lumenis both IPO > $1B).
- Ran Sela, CEO and co-founder: With over 15 years of medical device development and project management experience.
- Dr. Megel, CTO and co-founder: Bringing over 25 years of experience in ultrasound-based medical devices.
Current Phase of Development
Now, we are at the top-risk phase of our development journey: the transition from preclinical to clinical studies.
Funding and Future Plans
Leveraging an EC investment of €12.75M, we can:
- Demonstrate the efficacy and safety of our product.
- Establish a manufacturing line and regulatory framework.
- Access the market as a self-sustained company.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 11.369.502 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 31-8-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- HEALIUM MEDICAL LTDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Bypassing open heart surgery with Excimer Laser Assisted Non Occlusive Anastomosis (ELANA®)AMT Medical aims to revolutionize coronary artery disease treatment by developing a minimally invasive, cost-effective CABG surgery using innovative ELANA technology, seeking $7.5M for clinical validation and market entry. | EIC Accelerator | € 2.497.469 | 2022 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoringThe Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations. | EIC Accelerator | € 2.299.633 | 2023 | Details |
Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgeryThericon is developing an rMSI platform to enhance endoscopic cancer surgery by providing multi-parametric imaging for better tissue differentiation and reducing cancer recurrence, seeking funding for market launch in 2024. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Confident®, the digital simulation platform that revolutionizes cardiovascular interventionsConfident is an AI-driven platform that creates 3D virtual models for cardiovascular interventions, enabling personalized treatment planning to improve patient outcomes and reduce surgical risks. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Bypassing open heart surgery with Excimer Laser Assisted Non Occlusive Anastomosis (ELANA®)
AMT Medical aims to revolutionize coronary artery disease treatment by developing a minimally invasive, cost-effective CABG surgery using innovative ELANA technology, seeking $7.5M for clinical validation and market entry.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoring
The Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations.
Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgery
Thericon is developing an rMSI platform to enhance endoscopic cancer surgery by providing multi-parametric imaging for better tissue differentiation and reducing cancer recurrence, seeking funding for market launch in 2024.
Confident®, the digital simulation platform that revolutionizes cardiovascular interventions
Confident is an AI-driven platform that creates 3D virtual models for cardiovascular interventions, enabling personalized treatment planning to improve patient outcomes and reduce surgical risks.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Laesy Visualisatie 2.0Het project Laesie Visualisatie 2.0 ontwikkelt software voor verbeterde visualisatie van hartweefsel, wat leidt tot efficiëntere behandeling van hartritmestoornissen en lagere gezondheidskosten. | Mkb-innovati... | € 162.190 | 2020 | Details |
Closed-Loop and multisEnsing delIvery tool for controlled Laser Ablation of tumorsThe ERC LASER OPTIMAL project aims to develop a closed-loop control platform for laser ablation with fiber optic sensors to enhance precision in cancer treatment and facilitate market readiness. | ERC Proof of... | € 150.000 | 2022 | Details |
A Novel Handheld Ultrasound Medical Imaging Probe: Prototyping, Initial Validation and Business DevelopmentThe LucidWave Project aims to develop a low-cost, advanced handheld ultrasound probe for improved bedside diagnostics, enhancing medical decision-making and reducing misdiagnosis. | EIC Transition | € 2.427.025 | 2022 | Details |
SonicPrecision katheterogen bij ablatie van boezemfibrillerenSonicPrecision onderzoekt de haalbaarheid van een innovatieve ablatiekatheter met ultrasoundsensoren voor betere hartbehandelingen. | Mkb-innovati... | € 20.000 | 2024 | Details |
Novel microsensing platform for remote patient monitoringThe FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users. | EIC Transition | € 2.499.051 | 2023 | Details |
Laesy Visualisatie 2.0
Het project Laesie Visualisatie 2.0 ontwikkelt software voor verbeterde visualisatie van hartweefsel, wat leidt tot efficiëntere behandeling van hartritmestoornissen en lagere gezondheidskosten.
Closed-Loop and multisEnsing delIvery tool for controlled Laser Ablation of tumors
The ERC LASER OPTIMAL project aims to develop a closed-loop control platform for laser ablation with fiber optic sensors to enhance precision in cancer treatment and facilitate market readiness.
A Novel Handheld Ultrasound Medical Imaging Probe: Prototyping, Initial Validation and Business Development
The LucidWave Project aims to develop a low-cost, advanced handheld ultrasound probe for improved bedside diagnostics, enhancing medical decision-making and reducing misdiagnosis.
SonicPrecision katheterogen bij ablatie van boezemfibrilleren
SonicPrecision onderzoekt de haalbaarheid van een innovatieve ablatiekatheter met ultrasoundsensoren voor betere hartbehandelingen.
Novel microsensing platform for remote patient monitoring
The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.